Comparison between mitral valvuloplasy and mitral valve replacement in treatment of ventricular aneurysm complicated by ischemic mitral regurgitation
LIU Sheng
ZHONG Zhao-ji
SUN Han-song
SONG Yun-hu
LV Feng
WANG Shui-yun
WANG Xin
XU Jian-ping
FENG Wei
Abstract：Objective To compare the perioperative and long-term curative effect between mitral valvuloplasy (MVP) and mitral valve replacement (MVR) in treatment of ischemic mitral regurgitation (IMR) complicated by ventricular aneurysm.Methods The patients (n=49) undergone mitral valve operation were chosen from the Fuwai Hospital of Chinese Academy of Medical Sciences and Peking Union Medical College from July 2009 to Dec. 2015. All patients were divided, according to operation methods, into MVR group (n=9) and MVP group (n=40). The data from all patients were retrospectively analyzed and the patients were followed up for (3.1±2.0) y.Results The perioperative mortality had no statistical difference between 2 groups (P=0.569). IMR, left ventricular ejection fraction (LVEF) and left ventricular end-diastolic inner diameter (LVEDd) were significantly ameliorated in 2 groups before discharging from the hospital. LVEF was higher in MVP group than that in MVR group (P=0.016). There were 3 died cases during follow-up period. The long-term incidence of IMR was higher in MVP group than that in MVR group (P=0.020). LVEF and LVEDd had no statistical difference between 2 groups during final follow-up (P=0.981,P=0.596).Conclusion MVR and MVP have similar risk in patients with IMR complicated by ventricular aneurysm. There is long-term recrudescence risk after MVP, while there is no significant difference in long-term survival and heart function between MVR and MVP.
Keywords：Mitral valvuloplasyMitral valve replacementIschemic mitral regurgitationVentricular aneurysm
Publication Date：2017-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 164-167 )